95 related articles for article (PubMed ID: 4676339)
1. [Clinical study for augmentation of efficacy of anticancer drugs. 1. Combination therapy by proteolytic enzyme and anticancer drugs].
Kikuchi K; Aneha Y; Natsume R; Kanno H; Kunii Y
Nihon Gan Chiryo Gakkai Shi; 1972 Dec; 7(4):270-8. PubMed ID: 4676339
[No Abstract] [Full Text] [Related]
2. [Effect of polychemotherapy of cancer of the digestive organs].
Singer Z; Kobylińska-Scieszkowa M; Dzieza-Lalowicz I; Starzewska H; Rogoń Z; Gejsler A
Pol Tyg Lek; 1980 Sep; 35(38):1453-5. PubMed ID: 7465441
[No Abstract] [Full Text] [Related]
3. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.
O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET
Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870
[TBL] [Abstract][Full Text] [Related]
4. Clinical cancer chemotherapy aimed at potential cell regulators.
Knock FE; Galt RM; Renaud OV; Oester YT
Arch Surg; 1970 Feb; 100(2):167-72. PubMed ID: 5460788
[No Abstract] [Full Text] [Related]
5. [Experimental chemotherapy of human gastrointestinal and breast cancers in nude mice and its correlation to clinical effect].
Fujita M; Fujita F; Taguchi T
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1168-74. PubMed ID: 6433068
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy and cancer of the gastrointestinal tract.
Terz JJ; Beatty JD
Surg Annu; 1979; 11():149-80. PubMed ID: 388686
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for gastrointestinal cancer.
Giles GR; de Mello J
Br J Hosp Med; 1981 Jan; 25(1):15-22. PubMed ID: 7470714
[No Abstract] [Full Text] [Related]
8. Chemotherapy in alimentary tract malignomas.
Queisser W; Heim ME
Hepatogastroenterology; 1981 Oct; 28(5):276-83. PubMed ID: 6212524
[No Abstract] [Full Text] [Related]
9. Anticancer therapy with hydrea: comparative study of daily vs. intermittent oral dosage.
Ariel IM
J Surg Oncol; 1974; 6(1):73-8. PubMed ID: 4819359
[No Abstract] [Full Text] [Related]
10. [Potentiation of antineoplastic agents--significance of combination with urokinase].
Yamamoto M; Yamada T; Fukunaga K; Nagashima A; Nagamatsu S
Gan No Rinsho; 1971 Oct; 17(10):750-9. PubMed ID: 5166830
[No Abstract] [Full Text] [Related]
11. [Drug therapy in colonic and rectal cancer].
Cardoen G; Derluyn J; Jansen G
Tijdschr Gastroenterol; 1970; 13(1):54-63. PubMed ID: 5449033
[No Abstract] [Full Text] [Related]
12. Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma.
Trux F
Hepatogastroenterology; 1982 Jun; 29(3):130-3. PubMed ID: 7049880
[No Abstract] [Full Text] [Related]
13. Current trends and prospects in surgical adjuvant trials.
Rozencweig M; von Hoff DD; Louie AC; Muggia FM
Arch Geschwulstforsch; 1978; 48(7):673-9. PubMed ID: 282827
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of cancers of the colon and rectum].
Bleiberg H
Rev Med Brux; 1983 Mar; 4(3):145-6. PubMed ID: 6857050
[No Abstract] [Full Text] [Related]
15. [Chemotherapy and immunochemotherapy in colorectal neoplasms].
Nishi M; Uehara H; Ishizawa T; Kuwahara D; Yoshii H; Yotsumoto K; Aiko T
Nihon Rinsho; 1981 May; 39(5):2180-7. PubMed ID: 7026835
[No Abstract] [Full Text] [Related]
16. [Cancer of the large intestine. Modern chemotherapy and complementary methods].
Egger R
Rev Med Suisse Romande; 1983 Nov; 103(11):931-5. PubMed ID: 6665377
[No Abstract] [Full Text] [Related]
17. [Experience with weekly intravenous 5-fluorouracil in advanced colonic and rectal neoplasms].
Marcuello Gaspar E; Germa Lluch JR; Abad Esteve A; Badia Canto A
Rev Esp Enferm Apar Dig; 1979 Apr; 55(4):365-76. PubMed ID: 493637
[No Abstract] [Full Text] [Related]
18. Advances in the multimodal primary management of cancer.
DeVita VT; Henney JE; Weiss RB
Adv Intern Med; 1980; 26():115-29. PubMed ID: 7013437
[No Abstract] [Full Text] [Related]
19. [Results of chemotherapy in gastrointestinal malignancies].
Obrecht JP
Acta Med Austriaca Suppl; 1979; 6():303-11. PubMed ID: 299218
[TBL] [Abstract][Full Text] [Related]
20. [Experience and perspectives in the use of liposomal form of antineoplastic drugs in clinical oncology].
Shal'kov IuL; Dudnichenko AS; Krasnopol'skiĭ IuM
Klin Khir; 1995; (5):21-3. PubMed ID: 8646622
[No Abstract] [Full Text] [Related]
[Next] [New Search]
